Koninklijke Dsm Nv Stock Beta
| KDSKFDelisted Stock | USD 25.30 0.00 0.00% |
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke Pink Sheet. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM pink sheet.
Koninklijke |
Koninklijke DSM NV Company Beta Analysis
Koninklijke DSM's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Koninklijke DSM Beta | 0.71 |
Most of Koninklijke DSM's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Koninklijke DSM NV has a Beta of 0.7117. This is 18.2% lower than that of the Basic Materials sector and 35.3% lower than that of the Specialty Chemicals industry. The beta for all United States stocks is notably lower than that of the firm.
Koninklijke Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in beta category among its peers.
As returns on the market increase, Koninklijke DSM's returns are expected to increase less than the market. However, during the bear market, the loss of holding Koninklijke DSM is expected to be smaller as well.
Koninklijke Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 23.38 B | |||
| Shares Outstanding | 172.97 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 56.99 % | |||
| Price To Earning | 37.75 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.27 X | |||
| Revenue | 9.2 B | |||
| Gross Profit | 3.16 B | |||
| EBITDA | 1.71 B | |||
| Net Income | 1.68 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 9.44 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 2.51 X | |||
| Book Value Per Share | 56.38 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 6.71 X | |||
| Price To Earnings To Growth | 2.88 X | |||
| Number Of Employees | 21.76 K | |||
| Beta | 0.71 | |||
| Market Capitalization | 22.49 B | |||
| Total Asset | 16.01 B | |||
| Working Capital | 2.7 B | |||
| Current Asset | 4.9 B | |||
| Current Liabilities | 2.2 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 16.01 B | |||
| Last Dividend Paid | 2.63 |
About Koninklijke DSM Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Koninklijke DSM NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Koninklijke DSM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Koninklijke DSM NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Koninklijke Pink Sheet
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |